Exact Sciences Corporation share price logo

Exact Sciences Corporation

NASDAQ: EXAS

$104.94

+1.02

(+0.98%)

Live

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 20 Mar 2026

Exact Sciences Corporation Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $104.90
    $104.98
    downward going graph

    0.04%

    Downside

    0.04%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $38.81
    $104.98
    downward going graph

    63.02%

    Downside

    0.04%

    Upside

    downward going graph

Exact Sciences Corporation share price movements today

Previous Close
$103.92
Open
$104.94
Volume
17.2M
Day's Low - High
$104.90 - $104.98
52 Week Low - High
$38.81 - $104.98

Exact Sciences Corporation Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Exact Sciences Corporation Stock Fundamentals & Key Indicators

Check Exact Sciences Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Exact Sciences Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Exact Sciences Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%
BUY$44.8B6.27%43.2824.62%
HOLD$29.6B-2.13%28.5620.30%
BUY$171.9B-1.11%25.7715.15%
BUY$31.7B-15.89%25.2718.26%

Analyst Recommendation on Exact Sciences Corporation Stock

Based on 29 analysts

BUY

89.66%

Buy

10.34%

Hold

0.00%

Sell

Based on 29 analysts, 89.66% of analysts recommend a 'BUY' rating for Exact Sciences Corporation. Average target price of $105.81

Exact Sciences Corporation Share Price Target

Get share price movements and forecasts by analysts on Exact Sciences Corporation.

What analysts predicted

0.82%UPSIDE

Target Price

$105.81

Current Price

$104.94

Analyzed by

29 Analysts

Target

$105.81

Exact Sciences Corporation target price $105.81, a slight upside of 0.82% compared to current price of $104.94. According to 29 analysts rating.

Exact Sciences Corporation Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
628
646
637
699
708
713
706
811
850
878
Gross Profit
459
475
446
488
491
429
500
562
583
615
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
-49
-110
-15
-38
-864
-101
-1
-19
-85
Net Profit Margin
0.13%
-7.69%
-17.29%
-2.26%
-5.40%
-121.19%
-14.32%
-0.15%
-2.30%
-9.79%

Exact Sciences Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
99
265
454
876
1,491
1,767
2,084
2,499
2,758
3,246
Gross Profit
54
186
336
659
1,137
1,308
1,422
1,762
1,918
2,262
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-167
-114
-175
-213
-823
-595
-623
-204
-1,028
-207
Net Profit Margin
-168.26%
-43.01%
-38.54%
-24.32%
-55.22%
-33.71%
-29.91%
-8.17%
-37.29%
-6.40%

Global Institutional Holdings in Exact Sciences Corporation

Funds
Holdings
Pentwater Capital Management LP
3.8%
Wellington Management Company LLP
6.34%
Citadel Advisors Llc
2.06%
Ameriprise Financial Inc
2.35%
Renaissance Technologies Corp
0.83%

Exact Sciences Corporation News & Key Events

  • img

    Today's Timeline - 30 December

    Tue, 06:02 PM

    -

    Exact Sciences' financial results depend heavily on Cologuard's commercial success amid competitive pressures and macroeconomic challenges.

    Wed, 06:39 AM

    -

    Exact Sciences details accelerated bonus payouts for executives to mitigate golden parachute tax exposure amid acquisition discussions.

Insights on Exact Sciences Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EXAS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 706.78M → 878.38M (in $), with an average increase of 6.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, EXAS stock has moved up by 97.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EXAS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -1.18M → -85.95M (in $), with an average decrease of 946.1% per quarter

About Exact Sciences Corporation

Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
OrganisationExact Sciences Corporation
E-voting on sharesClick here to vote

FAQs

What is Exact Sciences Corporation share price today?

Exact Sciences Corporation share price today is $104.94 as on . Exact Sciences Corporation share today touched a day high of $104.98 and a low of $104.9.

What is the 52 week high and 52 week low for Exact Sciences Corporation share?

Exact Sciences Corporation share touched a 52 week high of $104.98 on and a 52 week low of $38.81 on . Exact Sciences Corporation stock price today i.e. is trending at $104.94,which is 0.04% down from its 52 week high and 170.38% up from its 52 week low.

How to invest in Exact Sciences Corporation Stock (EXAS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Exact Sciences Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Exact Sciences Corporation Shares that will get you 0.0143 shares as per Exact Sciences Corporation share price of $104.94 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Exact Sciences Corporation Stock (EXAS) from India?

Indian investors can start investing in Exact Sciences Corporation (EXAS) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Exact Sciences Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Exact Sciences Corporation share’s latest price of $104.94 as on March 21, 2026 at 1:29 am IST, you will get 0.0953 shares of Exact Sciences Corporation. Learn more about fractional shares .